MoneyWorks4Me

Mangalam Drugs & Organics informs about unaudited financial results

20 Nov 2017 Evaluate

Mangalam Drugs & Organics has informed about Unaudited Financial Results for the quarter and half year ended 30th September, 2017 along with Limited Review Report and the Statement of Assets & Liabilities of the said period in the prescribed form which have been taken on record and approved by the Board of Directors.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..